Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 3/1998

01-09-1998 | Leading Article

The Future Role of Anti-Tumour Necrosis Factor-α Products in the Treatment of Crohn's Disease

Authors: Dr Ruud A. van Hogezand, Hein W. Verspaget

Published in: Drugs | Issue 3/1998

Login to get access
Metadata
Title
The Future Role of Anti-Tumour Necrosis Factor-α Products in the Treatment of Crohn's Disease
Authors
Dr Ruud A. van Hogezand
Hein W. Verspaget
Publication date
01-09-1998
Publisher
Springer International Publishing
Published in
Drugs / Issue 3/1998
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-199856030-00001

Other articles of this Issue 3/1998

Drugs 3/1998 Go to the issue

Adis Drug Evaluation

Amphotericin-B Colloidal Dispersion

Disease Management

Rational Drug Therapy Recommendations for the Treatment of Patients with Sjögren's Syndrome

Adis Drug Evaluation

Levofloxacin

Adis Drug Evaluation

Omeprazole

Adis Drug Evaluation

Milnacipran

Adis Drug Evaluation

Domperidone